ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Axillary Hyperhidrosis Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-33N9235
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Axillary Hyperhidrosis Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Global Axillary Hyperhidrosis Drug Market Research Report 2025

Code: QYRE-Auto-33N9235
Report
September 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Allergan plc
Brickell Biotech Inc
Dermira
Dr. August Wolff GmbH & Co KG Arzneimittle
GlaxoSmithKline PLC
TheraVida
Dr. August Wolff GmbH & Co KG Arzneimittle

Axillary Hyperhidrosis Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Axillary Hyperhidrosis Drug Market

Axillary Hyperhidrosis Drug Market

The global market for Axillary Hyperhidrosis Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Axillary Hyperhidrosis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Axillary Hyperhidrosis Drug.
The Axillary Hyperhidrosis Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Axillary Hyperhidrosis Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Axillary Hyperhidrosis Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Axillary Hyperhidrosis Drug Market Report

Report Metric Details
Report Name Axillary Hyperhidrosis Drug Market
CAGR 5%
Segment by Type
Segment by Application
  • Clinic
  • Hospital
  • Home Care
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan Plc, Brickell Biotech Inc, Dermira Inc, Dr. August Wolff GmbH & Co KG Arzneimittle, GlaxoSmithKline Plc, TheraVida Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Axillary Hyperhidrosis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Axillary Hyperhidrosis Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Axillary Hyperhidrosis Drug Market report?

Ans: The main players in the Axillary Hyperhidrosis Drug Market are Allergan Plc, Brickell Biotech Inc, Dermira Inc, Dr. August Wolff GmbH & Co KG Arzneimittle, GlaxoSmithKline Plc, TheraVida Inc

What are the Application segmentation covered in the Axillary Hyperhidrosis Drug Market report?

Ans: The Applications covered in the Axillary Hyperhidrosis Drug Market report are Clinic, Hospital, Home Care

What are the Type segmentation covered in the Axillary Hyperhidrosis Drug Market report?

Ans: The Types covered in the Axillary Hyperhidrosis Drug Market report are Botulinum ToxinA, Glycopyrrolate, Glycopyrronium Tosylate, Others

Recommended Reports

Hyperhidrosis & Dermatology

Drug Delivery & Devices

Pharmaceuticals & Therapy

1 Axillary Hyperhidrosis Drug Market Overview
1.1 Product Definition
1.2 Axillary Hyperhidrosis Drug by Type
1.2.1 Global Axillary Hyperhidrosis Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Botulinum ToxinA
1.2.3 Glycopyrrolate
1.2.4 Glycopyrronium Tosylate
1.2.5 Others
1.3 Axillary Hyperhidrosis Drug by Application
1.3.1 Global Axillary Hyperhidrosis Drug Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Care
1.4 Global Axillary Hyperhidrosis Drug Market Size Estimates and Forecasts
1.4.1 Global Axillary Hyperhidrosis Drug Revenue 2020-2031
1.4.2 Global Axillary Hyperhidrosis Drug Sales 2020-2031
1.4.3 Global Axillary Hyperhidrosis Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Axillary Hyperhidrosis Drug Market Competition by Manufacturers
2.1 Global Axillary Hyperhidrosis Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Axillary Hyperhidrosis Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Axillary Hyperhidrosis Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Axillary Hyperhidrosis Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Axillary Hyperhidrosis Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Axillary Hyperhidrosis Drug, Product Type & Application
2.7 Global Key Manufacturers of Axillary Hyperhidrosis Drug, Date of Enter into This Industry
2.8 Global Axillary Hyperhidrosis Drug Market Competitive Situation and Trends
2.8.1 Global Axillary Hyperhidrosis Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Axillary Hyperhidrosis Drug Players Market Share by Revenue
2.8.3 Global Axillary Hyperhidrosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Axillary Hyperhidrosis Drug Market Scenario by Region
3.1 Global Axillary Hyperhidrosis Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Axillary Hyperhidrosis Drug Sales by Region: 2020-2031
3.2.1 Global Axillary Hyperhidrosis Drug Sales by Region: 2020-2025
3.2.2 Global Axillary Hyperhidrosis Drug Sales by Region: 2026-2031
3.3 Global Axillary Hyperhidrosis Drug Revenue by Region: 2020-2031
3.3.1 Global Axillary Hyperhidrosis Drug Revenue by Region: 2020-2025
3.3.2 Global Axillary Hyperhidrosis Drug Revenue by Region: 2026-2031
3.4 North America Axillary Hyperhidrosis Drug Market Facts & Figures by Country
3.4.1 North America Axillary Hyperhidrosis Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Axillary Hyperhidrosis Drug Sales by Country (2020-2031)
3.4.3 North America Axillary Hyperhidrosis Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Axillary Hyperhidrosis Drug Market Facts & Figures by Country
3.5.1 Europe Axillary Hyperhidrosis Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Axillary Hyperhidrosis Drug Sales by Country (2020-2031)
3.5.3 Europe Axillary Hyperhidrosis Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Axillary Hyperhidrosis Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Axillary Hyperhidrosis Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Axillary Hyperhidrosis Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Axillary Hyperhidrosis Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Axillary Hyperhidrosis Drug Market Facts & Figures by Country
3.7.1 Latin America Axillary Hyperhidrosis Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Axillary Hyperhidrosis Drug Sales by Country (2020-2031)
3.7.3 Latin America Axillary Hyperhidrosis Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Axillary Hyperhidrosis Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Axillary Hyperhidrosis Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Axillary Hyperhidrosis Drug Sales by Type (2020-2031)
4.1.1 Global Axillary Hyperhidrosis Drug Sales by Type (2020-2025)
4.1.2 Global Axillary Hyperhidrosis Drug Sales by Type (2026-2031)
4.1.3 Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2020-2031)
4.2 Global Axillary Hyperhidrosis Drug Revenue by Type (2020-2031)
4.2.1 Global Axillary Hyperhidrosis Drug Revenue by Type (2020-2025)
4.2.2 Global Axillary Hyperhidrosis Drug Revenue by Type (2026-2031)
4.2.3 Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2020-2031)
4.3 Global Axillary Hyperhidrosis Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Axillary Hyperhidrosis Drug Sales by Application (2020-2031)
5.1.1 Global Axillary Hyperhidrosis Drug Sales by Application (2020-2025)
5.1.2 Global Axillary Hyperhidrosis Drug Sales by Application (2026-2031)
5.1.3 Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2020-2031)
5.2 Global Axillary Hyperhidrosis Drug Revenue by Application (2020-2031)
5.2.1 Global Axillary Hyperhidrosis Drug Revenue by Application (2020-2025)
5.2.2 Global Axillary Hyperhidrosis Drug Revenue by Application (2026-2031)
5.2.3 Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2020-2031)
5.3 Global Axillary Hyperhidrosis Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan Plc
6.1.1 Allergan Plc Company Information
6.1.2 Allergan Plc Description and Business Overview
6.1.3 Allergan Plc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan Plc Axillary Hyperhidrosis Drug Product Portfolio
6.1.5 Allergan Plc Recent Developments/Updates
6.2 Brickell Biotech Inc
6.2.1 Brickell Biotech Inc Company Information
6.2.2 Brickell Biotech Inc Description and Business Overview
6.2.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Portfolio
6.2.5 Brickell Biotech Inc Recent Developments/Updates
6.3 Dermira Inc
6.3.1 Dermira Inc Company Information
6.3.2 Dermira Inc Description and Business Overview
6.3.3 Dermira Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Dermira Inc Axillary Hyperhidrosis Drug Product Portfolio
6.3.5 Dermira Inc Recent Developments/Updates
6.4 Dr. August Wolff GmbH & Co KG Arzneimittle
6.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Company Information
6.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Description and Business Overview
6.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Portfolio
6.4.5 Dr. August Wolff GmbH & Co KG Arzneimittle Recent Developments/Updates
6.5 GlaxoSmithKline Plc
6.5.1 GlaxoSmithKline Plc Company Information
6.5.2 GlaxoSmithKline Plc Description and Business Overview
6.5.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Portfolio
6.5.5 GlaxoSmithKline Plc Recent Developments/Updates
6.6 TheraVida Inc
6.6.1 TheraVida Inc Company Information
6.6.2 TheraVida Inc Description and Business Overview
6.6.3 TheraVida Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 TheraVida Inc Axillary Hyperhidrosis Drug Product Portfolio
6.6.5 TheraVida Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Axillary Hyperhidrosis Drug Industry Chain Analysis
7.2 Axillary Hyperhidrosis Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Axillary Hyperhidrosis Drug Production Mode & Process Analysis
7.4 Axillary Hyperhidrosis Drug Sales and Marketing
7.4.1 Axillary Hyperhidrosis Drug Sales Channels
7.4.2 Axillary Hyperhidrosis Drug Distributors
7.5 Axillary Hyperhidrosis Drug Customer Analysis
8 Axillary Hyperhidrosis Drug Market Dynamics
8.1 Axillary Hyperhidrosis Drug Industry Trends
8.2 Axillary Hyperhidrosis Drug Market Drivers
8.3 Axillary Hyperhidrosis Drug Market Challenges
8.4 Axillary Hyperhidrosis Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Allergan plc
Brickell Biotech Inc
Dermira
Dr. August Wolff GmbH & Co KG Arzneimittle
GlaxoSmithKline PLC
TheraVida
Dr. August Wolff GmbH & Co KG Arzneimittle
List of Tables
 Table 1. Global Axillary Hyperhidrosis Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Axillary Hyperhidrosis Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Axillary Hyperhidrosis Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Axillary Hyperhidrosis Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Axillary Hyperhidrosis Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Axillary Hyperhidrosis Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Axillary Hyperhidrosis Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Axillary Hyperhidrosis Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Axillary Hyperhidrosis Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Axillary Hyperhidrosis Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Axillary Hyperhidrosis Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Axillary Hyperhidrosis Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Axillary Hyperhidrosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Axillary Hyperhidrosis Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Axillary Hyperhidrosis Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Axillary Hyperhidrosis Drug Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Axillary Hyperhidrosis Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Axillary Hyperhidrosis Drug Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Axillary Hyperhidrosis Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Axillary Hyperhidrosis Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Axillary Hyperhidrosis Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Axillary Hyperhidrosis Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Axillary Hyperhidrosis Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Axillary Hyperhidrosis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Axillary Hyperhidrosis Drug Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Axillary Hyperhidrosis Drug Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Axillary Hyperhidrosis Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Axillary Hyperhidrosis Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Axillary Hyperhidrosis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Axillary Hyperhidrosis Drug Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Axillary Hyperhidrosis Drug Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Axillary Hyperhidrosis Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Axillary Hyperhidrosis Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Axillary Hyperhidrosis Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Axillary Hyperhidrosis Drug Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Axillary Hyperhidrosis Drug Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Axillary Hyperhidrosis Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Axillary Hyperhidrosis Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Axillary Hyperhidrosis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Axillary Hyperhidrosis Drug Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Axillary Hyperhidrosis Drug Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Axillary Hyperhidrosis Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Axillary Hyperhidrosis Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Axillary Hyperhidrosis Drug Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Axillary Hyperhidrosis Drug Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Axillary Hyperhidrosis Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Axillary Hyperhidrosis Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Axillary Hyperhidrosis Drug Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Axillary Hyperhidrosis Drug Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Axillary Hyperhidrosis Drug Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Axillary Hyperhidrosis Drug Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Axillary Hyperhidrosis Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Axillary Hyperhidrosis Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Axillary Hyperhidrosis Drug Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Axillary Hyperhidrosis Drug Price (USD/Pcs) by Application (2026-2031)
 Table 70. Allergan Plc Company Information
 Table 71. Allergan Plc Description and Business Overview
 Table 72. Allergan Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Allergan Plc Axillary Hyperhidrosis Drug Product
 Table 74. Allergan Plc Recent Developments/Updates
 Table 75. Brickell Biotech Inc Company Information
 Table 76. Brickell Biotech Inc Description and Business Overview
 Table 77. Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Brickell Biotech Inc Axillary Hyperhidrosis Drug Product
 Table 79. Brickell Biotech Inc Recent Developments/Updates
 Table 80. Dermira Inc Company Information
 Table 81. Dermira Inc Description and Business Overview
 Table 82. Dermira Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Dermira Inc Axillary Hyperhidrosis Drug Product
 Table 84. Dermira Inc Recent Developments/Updates
 Table 85. Dr. August Wolff GmbH & Co KG Arzneimittle Company Information
 Table 86. Dr. August Wolff GmbH & Co KG Arzneimittle Description and Business Overview
 Table 87. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product
 Table 89. Dr. August Wolff GmbH & Co KG Arzneimittle Recent Developments/Updates
 Table 90. GlaxoSmithKline Plc Company Information
 Table 91. GlaxoSmithKline Plc Description and Business Overview
 Table 92. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product
 Table 94. GlaxoSmithKline Plc Recent Developments/Updates
 Table 95. TheraVida Inc Company Information
 Table 96. TheraVida Inc Description and Business Overview
 Table 97. TheraVida Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. TheraVida Inc Axillary Hyperhidrosis Drug Product
 Table 99. TheraVida Inc Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Axillary Hyperhidrosis Drug Distributors List
 Table 103. Axillary Hyperhidrosis Drug Customers List
 Table 104. Axillary Hyperhidrosis Drug Market Trends
 Table 105. Axillary Hyperhidrosis Drug Market Drivers
 Table 106. Axillary Hyperhidrosis Drug Market Challenges
 Table 107. Axillary Hyperhidrosis Drug Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Axillary Hyperhidrosis Drug
 Figure 2. Global Axillary Hyperhidrosis Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Axillary Hyperhidrosis Drug Market Share by Type: 2024 & 2031
 Figure 4. Botulinum ToxinA Product Picture
 Figure 5. Glycopyrrolate Product Picture
 Figure 6. Glycopyrronium Tosylate Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Axillary Hyperhidrosis Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Axillary Hyperhidrosis Drug Market Share by Application: 2024 & 2031
 Figure 10. Clinic
 Figure 11. Hospital
 Figure 12. Home Care
 Figure 13. Global Axillary Hyperhidrosis Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Axillary Hyperhidrosis Drug Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Axillary Hyperhidrosis Drug Sales (2020-2031) & (K Pcs)
 Figure 16. Global Axillary Hyperhidrosis Drug Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Axillary Hyperhidrosis Drug Report Years Considered
 Figure 18. Axillary Hyperhidrosis Drug Sales Share by Manufacturers in 2024
 Figure 19. Global Axillary Hyperhidrosis Drug Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Axillary Hyperhidrosis Drug Players: Market Share by Revenue in Axillary Hyperhidrosis Drug in 2024
 Figure 21. Axillary Hyperhidrosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Axillary Hyperhidrosis Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Axillary Hyperhidrosis Drug Sales Market Share by Country (2020-2031)
 Figure 24. North America Axillary Hyperhidrosis Drug Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Axillary Hyperhidrosis Drug Sales Market Share by Country (2020-2031)
 Figure 28. Europe Axillary Hyperhidrosis Drug Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Axillary Hyperhidrosis Drug Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Axillary Hyperhidrosis Drug Revenue Market Share by Region (2020-2031)
 Figure 36. China Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Axillary Hyperhidrosis Drug Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Axillary Hyperhidrosis Drug Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Colombia Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Axillary Hyperhidrosis Drug Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Axillary Hyperhidrosis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Axillary Hyperhidrosis Drug by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Axillary Hyperhidrosis Drug by Type (2020-2031)
 Figure 59. Global Axillary Hyperhidrosis Drug Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Axillary Hyperhidrosis Drug by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Axillary Hyperhidrosis Drug by Application (2020-2031)
 Figure 62. Global Axillary Hyperhidrosis Drug Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Axillary Hyperhidrosis Drug Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Hyperhidrosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hyperhidrosis Machine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Axillary Hyperhidrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bromhidrosis Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiallergics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tree Nut Allergy Treatment Market Research Report 2024
Menopause Hormonal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microneedling Therapy Market Research Report 2025
Global Dandruff Treatment Market Research Report 2025
Menopause Hormonal Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Skin Hyperpigmentation Treatment Market Research Report 2025
Global Dermatological OTC Drugs Market Research Report 2024
Global Human Allergy Treatment Market Research Report 2025
Global Papular Urticaria Drug Market Research Report 2024
Global Antihistamines Market Research Report 2024
OTC Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Hypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Active Transdermal Drug Delivery Device Market Research Report 2024
Human Antihistamine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Medication for Facial Features Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4D16704
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions